Market Movers | Winners: BMBL, ARL, FIGS | Losers: CTNM, FMCC, IMXI
The S&P 500 edged down 0.1% on Monday, October 12, while the Nasdaq-100 declined 0.7% and the Dow Jones Industrial Average gained 0.4%. Over the past week the S&P 500 is up 0.4%, and over the past month it is up 2.0%.
Decliners outnumbered gainers 2,308 to 1,800 within the Trefis coverage universe. At the extremes, Bumble (BMBL) gained 49.6% and Contineum Therapeutics (CTNM) fell 36.0%.
Monday’s Market Winners
The 10 US-listed stocks in the Trefis coverage universe worth at least $300 million with the highest returns on Monday:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | BMBL | Bumble | 49.6% | 6.4% |
| 2 | ARL | American Realty Investors | 17.0% | 19.9% |
| 3 | FIGS | FIGS | 12.4% | 56.2% |
| 4 | FICO | Fair Isaac | 10.8% | -56.2% |
| 5 | CCC | CCC Intelligent Solutions | 8.1% | -4.5% |
| 6 | HELE | Helen Of Troy | 7.5% | 34.1% |
| 7 | ALHC | Alignment Healthcare | 7.2% | -59.0% |
| 8 | TRAX | First Tracks Biotherapeutics | 6.9% | n/a |
| 9 | VSXY | Victoria’s Secret | 6.9% | 63.5% |
| 10 | CBLL | CeriBell | 6.9% | 15.2% |
Monday’s Market Losers
And the 10 US-listed stocks in the Trefis coverage universe worth at least $300 million with the lowest returns on Monday:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CTNM | Contineum Therapeutics | -36.0% | -25.1% |
| 2 | FMCC | Federal Home Loan Mortgage | -14.4% | -68.9% |
| 3 | IMXI | International Money Express | -14.2% | -29.2% |
| 4 | FNMA | Federal National Mortgage Association Fannie Mae | -14.2% | -67.7% |
| 5 | SECZ | Securitize | -14.2% | n/a |
| 6 | TMC | TMC The Metals | -14.2% | -53.3% |
| 7 | QNC | Quantum eMotion | -10.8% | n/a |
| 8 | CBRS | Cerebras Systems | -10.7% | n/a |
| 9 | AEVA | Aeva Technologies | -10.6% | -8.1% |
| 10 | INDI | Indie Semiconductor | -10.6% | -34.1% |
Some Of Monday’s Biggest Moves Were Weeks In The Making
Contineum Therapeutics (CTNM) appears on both the one-day and one-month losers lists. It fell 36.0% on Monday and is down 42.2% over the past month; excluding Monday, it had already lost 9.7% over the other sessions.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest names in the Trefis coverage universe:
Winners
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | BMBL | Bumble | 49.0% | 6.4% |
| 2 | PCRX | Pacira BioSciences | 45.1% | 40.5% |
| 3 | OPCH | Option Care Health | 33.1% | -2.4% |
| 4 | PENG | Penguin Solutions | 30.4% | 304.7% |
| 5 | FIGS | FIGS | 30.2% | 56.2% |
| 6 | SCTX | Scribe Therapeutics | 27.5% | n/a |
| 7 | ARL | American Realty Investors | 22.1% | 19.9% |
| 8 | PTLO | Portillos | 20.3% | -5.9% |
| 9 | HPK | HighPeak Energy | 20.0% | 104.9% |
| 10 | CCI | Crown Castle | 19.9% | -5.3% |
Losers
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | AVBP | ArriVent BioPharma | -42.2% | -18.2% |
| 2 | ALMR | Alamar Biosciences | -36.4% | n/a |
| 3 | CTNM | Contineum Therapeutics | -32.7% | -25.1% |
| 4 | AXTI | AXT | -28.5% | 279.1% |
| 5 | EMAT | Evolution Metals & Technologies | -28.5% | n/a |
| 6 | CDNL | Cardinal Infrastructure | -27.1% | -13.5% |
| 7 | EOSE | Eos Energy Enterprises | -26.9% | -79.1% |
| 8 | PACB | Pacific Biosciences of California | -26.8% | 12.3% |
| 9 | ANGO | AngioDynamics | -26.6% | -11.2% |
| 10 | TWST | Twist Bioscience | -25.9% | 378.8% |
Movers Over The Last Month
And over the last 21 trading days, the strongest and weakest names in the Trefis coverage universe:
Winners
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | GRAL | GRAIL | 80.2% | n/a |
| 2 | DNA | Ginkgo Bioworks | 74.7% | 41.9% |
| 3 | IOVA | Iovance Biotherapeutics | 69.3% | 433.3% |
| 4 | PACB | Pacific Biosciences of California | 61.5% | 12.3% |
| 5 | P | Everpure | 58.2% | n/a |
| 6 | PENG | Penguin Solutions | 54.7% | 304.7% |
| 7 | BALY | Ballys | 52.6% | -15.3% |
| 8 | FOSL | Fossil | 51.2% | 90.2% |
| 9 | PTC | PTC | 48.6% | 11.6% |
| 10 | MRNA | Moderna | 48.5% | n/a |
Losers
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | LQDA | Liquidia | -58.5% | -19.8% |
| 2 | KDK | Kodiak AI | -53.5% | -84.1% |
| 3 | EMAT | Evolution Metals & Technologies | -52.3% | n/a |
| 4 | QURE | uniQure | -50.9% | -8.7% |
| 5 | GLAS | Glass House Brands | -48.5% | n/a |
| 6 | AVBP | ArriVent BioPharma | -43.2% | -18.2% |
| 7 | NKTR | Nektar Therapeutics | -42.9% | -5.8% |
| 8 | CTNM | Contineum Therapeutics | -42.2% | -25.1% |
| 9 | CDNL | Cardinal Infrastructure | -41.3% | -13.5% |
| 10 | FRMI | Fermi | -40.9% | -59.4% |
The Tape Rewards Attention. It Punishes Reaction
Big daily moves pull hard at both greed and fear, and acting on either, day after day, is how most portfolios end up trailing the index they were trying to beat.
The Trefis High Quality (HQ) Portfolio is built for the opposite reflex: about 30 quality businesses screened for the fundamentals that survive volatile stretches, held with rules instead of reactions. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Read the movers daily; trade them rarely.